Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Verhamme (Rotterdam, Netherlands), M. Clyncke (Ghent, Belgium), L. Lahousse (Ghent, Belgium), E. Baan (Rotterdam, Netherlands), G. Brusselle (Ghent, Belgium). Real world use of opioids in COPD patients. 2688

Member's Comments

No comment yet.

Related content which might interest you: Real world patient experience of home spirometry within a UK ILD centre Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia Year: 2021 Real life assessment of inhaler use and acute exacerbations in 2935 COPD patients Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Real current situation of management and for patient with asthma at community Source: Annual Congress 2012 - Diagnostic insights and decision making in primary care Year: 2012 Describing “real world” COPD patients in primary care in Germany – Findings of the BeoNet-Registry Source: International Congress 2018 – Primary care management of COPD Year: 2018 Real prevalence of severe asthma in developing countries – Is the diagnosis correct? Source: Virtual Congress 2020 – Clinical parameters in severe asthma Year: 2020 Real world outcomes of Mepolizumab for severe asthma in Wales a retrospective analysis. Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Inhaled corticosteroid related pneumonia in real world among the patients with asthma and COPD Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Real-world medication use patterns in stable COPD patients from Romania Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 Characteristics of new users of aclidinium, aclidinium/formoterol, and other COPD medications in three European countries Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases Year: 2020 The drug costs associated with COPD prescription medicine in Denmark Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management Year: 2012 Efficacy of azithromycin in a real world severe asthma cohort Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Real life study showing the epidemiological profile and adherence to treatment of patients with severe allergic asthma in use of omalizumab in the past year. Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018 Should we exercise caution with benzodiazepine use in patients with COPD? Source: Eur Respir J 2014; 44: 284-286 Year: 2014 The rationality of the use of NIV in elderly patients with acute COPD exacerbation Source: International Congress 2018 – Non-invasive ventilation for acute respiratory failure Year: 2018 The use of Prevexair application in patients with COPD. Source: International Congress 2019 – Clinical implications of COPD management Year: 2019 Opioid prescription for severe chronic breathlessness to hospitalised patients with COPD - a clinical audit Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 The effects of real-time telemedicine consultations between hospital-based nurses and severe COPD patients discharged after exacerbation admissions Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education Year: 2013 Lung function, symptoms and prescription of inhaled steroids and long acting β2 agonists in patients managed by an integrated COPD team Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Analysis of two-year treatment with omalizumab patients with severe asthma in real clinical practice Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019